Logo

Kevin Hrusovsky

Mar 04, 2015

Quanterix announced that Kevin Hrusovsky has been appointed CEO. He will continue to serve as executive chairman of the firm's board of directors. Hrusovsky brings over 20 years of experience in the life science and diagnostics industries. Prior to joining Quanterix, he was president of Life Sciences and Technologies at PerkinElmer, CEO of Caliper Life Sciences, and CEO of Zymark.

Breaking News
The Scan

Sick Newborns Selected for WGS With Automated Pipeline

Researchers successfully prioritized infants with potential Mendelian conditions for whole-genome sequencing or rapid whole-genome sequencing, as they report in Genome Medicine.

Acne-Linked Loci Found Through GWAS Meta-Analysis

Researchers in the European Journal of Human Genetics find new and known acne vulgaris risk loci with a genome-wide association study and meta-analysis, highlighting hair follicle- and metabolic disease-related genes.

Retina Cell Loss Reversed by Prime Editing in Mouse Model of Retinitis Pigmentosa

A team from China turns to prime editing to correct a retinitis pigmentosa-causing mutation in the PDE6b gene in a mouse model of the progressive photoreceptor loss condition in the Journal of Experimental Medicine.

CRISPR Screens Reveal Heart Attack-Linked Gene

Researchers in PLOS Genetics have used CRISPR screens to home in on variants associated with coronary artery disease that affect vascular endothelial function.